Indium (111In) biciromab
|Target||Fibrin II, beta chain|
|(what is this?)|
Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood. It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism, but was withdrawn during clinical trials.
- King DJ, Adair JR (March 1999). "Recombinant antibodies for the diagnosis and therapy of human diseases". Current Opinion in Drug Discovery & Development. 2 (2): 110–7. PMID 19649936.
- "Centocor Ortho Biotech Products, L.P." Answers.com.
- "Centocor withdraws imaging agent applications". DiagnosticImaging.com.